Since the complex formed by BRD4 binding to CDK9/P-TEFb is localized in the SEs region and stimulates the transcriptional activation of MYC, synergistic inhibition of these two targets can effectively halt the progression of cancer (Lovén et al., 2013; Lu et al., 2015). The gene discussed is MYC; the disease is cancer.